IS DE NOVO USE OF ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITORS ASSOCIATED WITH IMPROVED OUTCOMES IN PEOPLE WITH NEWLY DIAGNOSED HEART FAILURE?

Category Primary study
ConferenceAmerican College of Cardiology, (ACC) Meeting 2025
Year 2025
This article has no abstract
Epistemonikos ID: bd8a05af12a51b707d67edd42005d78de0016e24
First added on: Mar 21, 2025